Skip to main content

Tm Bioscience to be Listed on Toronto Stock Exchange; Plans Share Consolidation

NEW YORK, Feb. 27 (GenomeWeb News) - Tm Bioscience has received conditional approval to list its common shares on the Toronto Stock Exchange, the company said yesterday.

 

The Toronto-based company expects full approval by May 26. CEO and president Greg Hines said he hopes the listing will "greatly enhance our profile among a broader group of investors."

 

Tm Bioscience also plans to consolidate its shares by converting each five common shares into one. It intends to obtain shareholder approval for this share consolidation at its annual meeting, scheduled for June 2.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.